ID   FRK_HUMAN               Reviewed;         505 AA.
AC   P42685; B4DY49; Q13128; Q9NTR5;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   15-MAR-2017, entry version 176.
DE   RecName: Full=Tyrosine-protein kinase FRK;
DE            EC=2.7.10.2;
DE   AltName: Full=FYN-related kinase;
DE   AltName: Full=Nuclear tyrosine protein kinase RAK;
DE   AltName: Full=Protein-tyrosine kinase 5;
GN   Name=FRK; Synonyms=PTK5, RAK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=7696183;
RA   Cance W.G., Craven R.J., Bergman M., Xu L.H., Alitalo K., Liu E.T.;
RT   "Rak, a novel nuclear tyrosine kinase expressed in epithelial cells.";
RL   Cell Growth Differ. 5:1347-1355(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lymphoid tissue;
RX   PubMed=7510261; DOI=10.1016/0378-1119(94)90817-6;
RA   Lee J., Wang Z., Luoh S.-M., Wood W.I., Scadden D.T.;
RT   "Cloning of FRK, a novel human intracellular SRC-like tyrosine kinase-
RT   encoding gene.";
RL   Gene 138:247-251(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8099900; DOI=10.1002/ijc.2910540409;
RA   Cance W.G., Craven R.J., Weiner T.M., Liu E.T.;
RT   "Novel protein kinases expressed in human breast cancer.";
RL   Int. J. Cancer 54:571-577(1993).
RN   [8]
RP   INTERACTION WITH RB1.
RX   PubMed=7664264;
RA   Craven R.J., Cance W.G., Liu E.T.;
RT   "The nuclear tyrosine kinase Rak associates with the retinoblastoma
RT   protein pRb.";
RL   Cancer Res. 55:3969-3972(1995).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   FUNCTION, INTERACTION WITH PTEN, AND MUTAGENESIS OF LYS-262.
RX   PubMed=19345329; DOI=10.1016/j.ccr.2009.02.012;
RA   Yim E.-K., Peng G., Dai H., Hu R., Li K., Lu Y., Mills G.B.,
RA   Meric-Bernstam F., Hennessy B.T., Craven R.J., Lin S.-Y.;
RT   "Rak functions as a tumor suppressor by regulating PTEN protein
RT   stability and function.";
RL   Cancer Cell 15:304-314(2009).
RN   [11]
RP   REVIEW ON FUNCTION.
RX   PubMed=19652529; DOI=10.4161/cc.8.17.9389;
RA   Brauer P.M., Tyner A.L.;
RT   "RAKing in AKT: a tumor suppressor function for the intracellular
RT   tyrosine kinase FRK.";
RL   Cell Cycle 8:2728-2732(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40 AND THR-178, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-100; ARG-122 AND LEU-133.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Non-receptor tyrosine-protein kinase that negatively
CC       regulates cell proliferation. Positively regulates PTEN protein
CC       stability through phosphorylation of PTEN on 'Tyr-336', which in
CC       turn prevents its ubiquitination and degradation, possibly by
CC       reducing its binding to NEDD4. May function as a tumor suppressor.
CC       {ECO:0000269|PubMed:19345329}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- SUBUNIT: Interacts (via the SH3-domain) with PTEN. Interacts with
CC       RB1. {ECO:0000269|PubMed:19345329, ECO:0000269|PubMed:7664264}.
CC   -!- INTERACTION:
CC       Q12982:BNIP2; NbExp=4; IntAct=EBI-1383583, EBI-752094;
CC       P60484:PTEN; NbExp=7; IntAct=EBI-1383583, EBI-696162;
CC       P06400:RB1; NbExp=3; IntAct=EBI-1383583, EBI-491274;
CC       Q15427:SF3B4; NbExp=4; IntAct=EBI-1383583, EBI-348469;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:7696183}.
CC       Nucleus {ECO:0000269|PubMed:7696183}. Note=Predominantly found in
CC       the nucleus, with a small fraction found in the cell periphery.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P42685-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P42685-2; Sequence=VSP_056496, VSP_056497;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in epithelial derived
CC       cell lines and tissues, especially normal liver, kidney, breast
CC       and colon. {ECO:0000269|PubMed:7696183}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. SRC subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U22322; AAC50116.1; -; mRNA.
DR   EMBL; U00803; AAA18284.1; -; mRNA.
DR   EMBL; AK302264; BAG63611.1; -; mRNA.
DR   EMBL; AL021451; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL121963; CAB87592.2; -; Genomic_DNA.
DR   EMBL; AL357141; CAB87592.2; JOINED; Genomic_DNA.
DR   EMBL; AL357141; CAI16469.1; -; Genomic_DNA.
DR   EMBL; AL121963; CAI16469.1; JOINED; Genomic_DNA.
DR   EMBL; CH471051; EAW48241.1; -; Genomic_DNA.
DR   EMBL; BC012916; AAH12916.1; -; mRNA.
DR   CCDS; CCDS5103.1; -. [P42685-1]
DR   PIR; I38396; I38396.
DR   RefSeq; NP_002022.1; NM_002031.2. [P42685-1]
DR   RefSeq; XP_005266937.1; XM_005266880.4. [P42685-1]
DR   RefSeq; XP_005266938.1; XM_005266881.2. [P42685-1]
DR   RefSeq; XP_005266939.1; XM_005266882.4. [P42685-1]
DR   RefSeq; XP_011533955.1; XM_011535653.2. [P42685-1]
DR   RefSeq; XP_011533956.1; XM_011535654.2. [P42685-1]
DR   RefSeq; XP_011533957.1; XM_011535655.2. [P42685-1]
DR   RefSeq; XP_016866134.1; XM_017010645.1. [P42685-1]
DR   UniGene; Hs.89426; -.
DR   ProteinModelPortal; P42685; -.
DR   SMR; P42685; -.
DR   BioGrid; 108726; 10.
DR   IntAct; P42685; 10.
DR   MINT; MINT-3015573; -.
DR   STRING; 9606.ENSP00000357615; -.
DR   BindingDB; P42685; -.
DR   ChEMBL; CHEMBL4223; -.
DR   DrugBank; DB08896; Regorafenib.
DR   GuidetoPHARMACOLOGY; 2025; -.
DR   iPTMnet; P42685; -.
DR   PhosphoSitePlus; P42685; -.
DR   BioMuta; FRK; -.
DR   DMDM; 1169745; -.
DR   MaxQB; P42685; -.
DR   PaxDb; P42685; -.
DR   PeptideAtlas; P42685; -.
DR   PRIDE; P42685; -.
DR   TopDownProteomics; P42685-1; -. [P42685-1]
DR   DNASU; 2444; -.
DR   Ensembl; ENST00000606080; ENSP00000476145; ENSG00000111816. [P42685-1]
DR   GeneID; 2444; -.
DR   KEGG; hsa:2444; -.
DR   UCSC; uc003pwi.2; human. [P42685-1]
DR   CTD; 2444; -.
DR   DisGeNET; 2444; -.
DR   GeneCards; FRK; -.
DR   HGNC; HGNC:3955; FRK.
DR   HPA; CAB025217; -.
DR   HPA; HPA057484; -.
DR   MIM; 606573; gene.
DR   neXtProt; NX_P42685; -.
DR   OpenTargets; ENSG00000111816; -.
DR   PharmGKB; PA28373; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000118938; -.
DR   HOGENOM; HOG000233858; -.
DR   HOVERGEN; HBG008761; -.
DR   InParanoid; P42685; -.
DR   KO; K08892; -.
DR   OMA; IRTNKFS; -.
DR   OrthoDB; EOG091G0D46; -.
DR   PhylomeDB; P42685; -.
DR   TreeFam; TF351634; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; P42685; -.
DR   ChiTaRS; FRK; human.
DR   GeneWiki; Fyn-related_kinase; -.
DR   GenomeRNAi; 2444; -.
DR   PRO; PR:P42685; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000111816; -.
DR   CleanEx; HS_FRK; -.
DR   Genevisible; P42685; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005622; C:intracellular; TAS:ProtInc.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0035580; C:specific granule lumen; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0005102; F:receptor binding; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0016477; P:cell migration; IBA:GO_Central.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; SH2 domain; SH3 domain; Transferase;
KW   Tumor suppressor; Tyrosine-protein kinase.
FT   CHAIN         1    505       Tyrosine-protein kinase FRK.
FT                                /FTId=PRO_0000088097.
FT   DOMAIN       42    110       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN      116    208       SH2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   DOMAIN      234    491       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     240    248       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    354    354       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     262    262       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      37     37       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES      40     40       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     178    178       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     387    387       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250}.
FT   VAR_SEQ       1     13       MSNICQRLWEYLE -> MDSTSLLPNPWIR (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056496.
FT   VAR_SEQ      14    155       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056497.
FT   VARIANT     100    100       I -> V (in dbSNP:rs34704018).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041702.
FT   VARIANT     122    122       G -> R (in dbSNP:rs3756772).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_006283.
FT   VARIANT     133    133       S -> L (in dbSNP:rs34064900).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041703.
FT   MUTAGEN     262    262       K->R: Loss of ability to phosphorylate
FT                                PTEN. {ECO:0000269|PubMed:19345329}.
FT   CONFLICT    115    115       P -> A (in Ref. 1; AAC50116).
FT                                {ECO:0000305}.
SQ   SEQUENCE   505 AA;  58254 MW;  06EC050DDBCD930B CRC64;
     MSNICQRLWE YLEPYLPCLS TEADKSTVIE NPGALCSPQS QRHGHYFVAL FDYQARTAED
     LSFRAGDKLQ VLDTLHEGWW FARHLEKRRD GSSQQLQGYI PSNYVAEDRS LQAEPWFFGA
     IGRSDAEKQL LYSENKTGSF LIRESESQKG EFSLSVLDGA VVKHYRIKRL DEGGFFLTRR
     RIFSTLNEFV SHYTKTSDGL CVKLGKPCLK IQVPAPFDLS YKTVDQWEID RNSIQLLKRL
     GSGQFGEVWE GLWNNTTPVA VKTLKPGSMD PNDFLREAQI MKNLRHPKLI QLYAVCTLED
     PIYIITELMR HGSLQEYLQN DTGSKIHLTQ QVDMAAQVAS GMAYLESRNY IHRDLAARNV
     LVGEHNIYKV ADFGLARVFK VDNEDIYESR HEIKLPVKWT APEAIRSNKF SIKSDVWSFG
     ILLYEIITYG KMPYSGMTGA QVIQMLAQNY RLPQPSNCPQ QFYNIMLECW NAEPKERPTF
     ETLRWKLEDY FETDSSYSDA NNFIR
//
